Clinical Trial: A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Basic Science
Study Type: INTERVENTIONAL
Official Title: A Randomized, Placebo- and Positive-controlled, Crossover Study to Assess the Effect of Olpasiran (AMG 890) on QT/QTc Intervals in Healthy Subjects
Brief Summary:
The primary objective of the study is:• To assess the effects of a single therapeutic and supratherapeutic dose of olpasiran on the placebo-corrected change from baseline in QT corrected for heart rate (??QT)/QTc interval in healthy participants.
Read more